Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03003104 · ClinicalTrials.gov registry record · Phase 2
DMT210 Topical Gel in the Treatment of Acne Rosacea
A Phase 2 study, sponsored by Dermata Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 107
- Enrollment target
NCT03003104: Completed Phase 2 study, sponsored by Dermata Therapeutics.
NCT03003104 is a Phase 2 study that has completed, run by Dermata Therapeutics. The registered enrollment target is 107 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (20% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03003104, a Phase 2 study, has completed, sponsored by Dermata Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 107 participants
- Enrollment target
Study Summary
The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of participants will receive DMT210 Gel while the other half will receive vehicle control.
Primary Outcome
Inflammatory lesion counts
Interventions
- OTHER Vehicle Control
- DRUG DMT210 Topical Gel 5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-08-30 |
| Phase | Phase 2 |
What the finished NCT03003104 record still lists
NCT03003104 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (20% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle Control is the first listed.
NCT03003104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03003104 about?
NCT03003104 is a clinical study titled "DMT210 Topical Gel in the Treatment of Acne Rosacea". The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of participants will receive DMT210 Gel while the other half will receive vehicle control.
What is the current status of trial NCT03003104?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 107 participants. The study started on 2017-01. Estimated completion is 2017-08-30.
What interventions are being tested in trial NCT03003104?
The interventions under investigation include: Vehicle Control (OTHER), DMT210 Topical Gel 5% (DRUG).
Who is sponsoring clinical trial NCT03003104?
This trial is sponsored by Dermata Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03003104's enrollment target sits among peer trials
107 646th of 2000 higher than 1,353 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia